Positive drug stories: possibilities for agency and positive subjectivity for harm reduction

References

• Ahern J, Stuber J, Galea S. 2007. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 88:188–196.
   PubMed Web of Science ®Google Scholar
• Askew R, Bone M. 2019. Deconstructing prohibitionist ideology: a sociocognitive approach to understand opinions on UK drug policy and the law. Int J Drug Policy. 74:33–40.
   PubMed Web of Science ®Google Scholar
• Barratt MJ, Lenton S. 2010. Beyond recruitment? Participatory online research with people who use drugs. Int J Internet Res Ethics. 3:69–86.
   Google Scholar
• Barratt MJ, Maddox A. 2016. Active engagement with stigmatised communities through digital ethnography. Qual Res. 16:701–719.
   Web of Science ®Google Scholar
• Birtel MD, Wood L, Kempa NJ. 2017. Stigma and social support in substance abuse: implications for mental health and well-being. Psychiatry Res. 252:1–8.
   PubMed Web of Science ®Google Scholar
• Bishop BJ, Sonn CC, Drew NM, Contos NE. 2002. The evolution of epistemology and concepts in an iterative‐generative reflective practice: the importance of small differences. Am J Community Psychol. 30:493–510.
   PubMed Web of Science ®Google Scholar
• Bluelight.org. 2020. Bluelight’s Mission Statement. [accessed 2020 Aug 12]. https://www.bluelight.org/xf/pages/Mission_Statement/.
   Google Scholar
• Bohling F. 2017. Psychedelic pleasures: an affective understanding of the joys of tripping. Int J Drug Policy. 49:133–143.
   PubMed Web of Science ®Google Scholar
• Bosch T. 2008. Online coloured identities: a virtual ethnography. In: Hadland A, Louw E, Sesanti S, Wasserman H, editors. Power, politics and identity in South African media. Cape Town (South Africa): HSRC Press; p. 184–203.
   Google Scholar
• Bourgois P. 2018. Decolonising drug studies in an era of predatory accumulation. Third World Q. 39:385–398.
   PubMed Web of Science ®Google Scholar
• Braun V, Clarke V. 2006. Using thematic analysis in psychology. Qual Res Psychol. 3:77–101.
   Google Scholar
• Bright SJ, Bishop B, Kane R, Marsh A, Barratt MJ. 2013. Kronic hysteria: exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm. Int J Drug Policy. 24:231–237.
   PubMed Web of Science ®Google Scholar
• Bright SJ, Marsh A, Smith LM, Bishop B. 2008. What can we say about substance use? Dominant discourses and narratives emergent from Australian media. Addict Res Theory. 16:135–148.
   Web of Science ®Google Scholar
• Bright SJ, Kane R, Bishop B, Marsh A. 2014. Development of the Australian Dominant Drug Discourses Scale. Addict Res Theory. 22:416–423.
   Web of Science ®Google Scholar
• Bunton R, Coveney J. 2011. Drugs’ pleasures. Crit Public Health. 21:9–23.
   Web of Science ®Google Scholar
• Charmaz K. 2004. Premises, principles, and practices in qualitative research: revisiting the foundations. Qual Health Res. 14:976–993.
   PubMed Web of Science ®Google Scholar
• Duff C. 2008. The pleasure in context. Int J Drug Policy. 19:384–392.
   PubMed Web of Science ®Google Scholar
• Dwyer R. 2008. Privileging pleasure: temazepam injection in a heroin marketplace. Int J Drug Policy. 19:367–374.
   PubMed Web of Science ®Google Scholar
• Dzidic PL. 2010. Influences of worldviews, values and mythologies in Australian rural landscapes: considering culture, change, and transition [dissertation]. Perth: Curtin University.
   Google Scholar
• Engel L. 2020. An online Australian drug discussion: Illicit drug policy and the Australian Drug Discussion (AusDD) forum [dissertation]. Canberra: Canberra University.
   Google Scholar
• Enghoff O, Aldridge J. 2019. The value of unsolicited online data in drug policy research. Int J Drug Policy. 73:210–218.
   PubMed Web of Science ®Google Scholar
• Farrugia A, Fraser S. 2017a. Science and scepticism: Drug information, young men and counterpublic health. Health (London). 21:595–615.
   PubMed Web of Science ®Google Scholar
• Farrugia A, Fraser S. 2017b. Young brains at risk: Co-constituting youth and addiction in neuroscience-informed Australian drug eduction. BioSocieties. 12:588–610.
   Web of Science ®Google Scholar
• Foucault M. 1978. The history of sexuality. Vol 1. An introduction (R. Hurley, Trans.) London: Penguin Press.
   Google Scholar
• Foucault M. 1986. The history of sexuality. Vol 2. The use of pleasure (R. Hurley, Trans.) London: Penguin Press.
   Google Scholar
• Foucault M. 1990. The history of sexuality. Vol 3. The care of the self (R. Hurley, Trans.) Allen Lane: Penguin Press.
   Google Scholar
• Fraser S, Pienaar K, Dilkes-Frayne E, Moore D, Kokanovic R, Treloar C, Dunlop A. 2017. Addiction stigma and the biopolitics of liberal modernity: a qualitative analysis. Int J Drug Policy. 44:192–201.
   PubMed Web of Science ®Google Scholar
• Haythornthwaite C. 2007. Social networks and online community. In: Joinson AN, McKenna KYA, Postmes T, Reips UD. The Oxford handbook of Internet psychology. Oxford: OUP; p. 121–137.
   Google Scholar
• Jacinto C, Duterte M, Sales P, Murphy S. 2008. Maximising the highs and minimising the lows: Harm reduction guidance within ecstasy distribution networks. Int J Drug Policy. 19:393–400.
   PubMed Web of Science ®Google Scholar
• Järvinen M. 2017. From wanting to willing – controlled drug use as a treatment goal. Soc Sci Med. 176:69–76.
   PubMed Web of Science ®Google Scholar
• Jones N, Corrigan PW. 2014. The stigma of disease and disability: understanding causes and overcoming injustices. Washington (DC): American Psychological Association.
   Google Scholar
• Keane H. 2008. Pleasure and discipline in the uses of Ritalin. Int J Drug Policy. 19:401–409.
   PubMed Web of Science ®Google Scholar
• Kjellgren A, Soussan C. 2014. The flip side of ‘Spice’: the adverse effects of synthetic cannabinoids as discussed on a Swedish internet forum. Nordic Stud Alcohol Drugs. 31:207–220.
   Web of Science ®Google Scholar
• Kulesza M, Larimer ME, Rao D. 2013. Substance use related stigma: what we know and the way forward. J Addict Behav Ther Rehabil. 2:782.
   PubMedGoogle Scholar
• Lafferty L, Treloar C, Van Breda N, Steele M, Hiley S, Flaherty I, Salmon A. 2017. ‘It’s fast, it’s quick, it stops me being sick’: how to influence preparation of opioid tablets for injection. Drug Alcohol Rev. 36:651–657.
   PubMed Web of Science ®Google Scholar
• Lancaster K, Seear K, Ritter A. 2017. Making medicine; producing pleasure: a critical examination of medicinal cannabis policy and law in Victoria, Australia. Int J Drug Policy. 49:117–125.
   PubMed Web of Science ®Google Scholar
• Lancaster K, Seear K, Treloar C. 2015. Laws prohibiting peer distribution of injecting equipment in Australia: a critical analysis of their effects. Int J Drug Policy. 26:1198–1206.
   PubMed Web of Science ®Google Scholar
• Lee H, Petersen S. 2009. Demarginalizing the marginalized in substance abuse treatment: stories of homeless, active substance users in an urban harm reduction based drop-in center. Addict Res Theory. 17:622–636.
   Web of Science ®Google Scholar
• Lingel J, Boyd d. 2013. “Keep it secret, keep it safe”: information poverty, information norms, and stigma. J Am Soc Inf Sci Tec. 64:981–991.
   Web of Science ®Google Scholar
• Luoma JB, Twohig MP, Waltz T, Hayes SC, Roget N, Padilla M, Fisher G. 2007. An investigation of stigma in individuals receiving treatment for substance abuse. Addict Behav. 32:1331–1346.
   PubMed Web of Science ®Google Scholar
• Lupton D. 1999. Risk. New York: Routledge.
   Google Scholar
• MacLean S. 2008. Volatile bodies: stories of corporeal pleasure and damage in marginalised young people’s drug use. Int J Drug Policy. 19:375–383.
   PubMed Web of Science ®Google Scholar
• Månsson J, Ekendahl M. 2013. Legitimacy through scaremongering: the discursive role of alcohol in online discussions of cannabis use and policy. Addict Res Theory. 21:469–478.
   Web of Science ®Google Scholar
• McCosker A. 2017. Networks of advocacy and influence: peer mentors in beyondblue’s mental health forums. Melbourne (Australia): Swinburne Social Innovation Research Institute.
   Google Scholar
• McCosker A, Hartup M. 2018. Turning to online peer forums for suicide and self-harm support: “it does help having you guys”. Melbourne (Australia): beyondblue and Swinburne Social Innovation Research Institute.
   Google Scholar
• Moore D. 2008. Erasing pleasure from public discourse on illicit drugs: on the creation and reproduction of an absence. Int J Drug Policy. 19:353–358.
   PubMed Web of Science ®Google Scholar
• Móró L, Rácz J. 2013. Online drug user-led harm reduction in Hungary: a review of “Daath”. Harm Reduct J. 10:18.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Halkitis P, Kiang M. 2013. Perceived public stigma and stigmatization in explaining lifetime illicit drug use among emerging adults. Addict Res Theory. 21:516–525.
   Web of Science ®Google Scholar
• Palamar JJ. 2012. A pilot study examining perceived rejection and secrecy in relation to illicit drug use and associated stigma. Drug Alcohol Rev. 31:573–579.
   PubMed Web of Science ®Google Scholar
• Race K. 2008. The use of pleasure in harm reduction: Perspectives from the history of sexuality. Int J Drug Policy. 19:417–423.
   PubMed Web of Science ®Google Scholar
• Rødner S. 2005. “I am not a drug abuser, I am a drug user”: a discourse analysis of 44 drug users’ construction of identity. Addict Res Theory. 13:333–346.
   Web of Science ®Google Scholar
• Semple SJ, Grant I, Patterson TL. 2005. Utilization of drug treatment programs by methamphetamine users: the role of social stigma. Am J Addict. 14:367–380.
   PubMed Web of Science ®Google Scholar
• Soussan C, Kjellgren A. 2015. Chasing the high’ – experiences of ethylphenidate as described on international internet forums. Substance Abuse: Res Treat. 9:9–16.
   Web of Science ®Google Scholar
• Stevens A. 2019. ‘Being human’ and the ‘moral sidestep’ in drug policy: explaining government inaction on opioid-related deaths in the UK. Addict Behav. 90:444–450.
   PubMed Web of Science ®Google Scholar
• Szmigin I, Griffin C, Mistral W, Bengry-Howell A, Weale L, Hackley C. 2008. Re-framing ‘binge drinking’ as calculated hedonism: empirical evidence from the UK. Int J Drug Policy. 19:359–366.
   PubMed Web of Science ®Google Scholar
• Taylor S, Buchanan J, Ayres TC. 2016. Prohibition, privilege and the drug apartheid: the failure of drug policy reform to address the underlying fallacies of drug prohibition. Criminol Crim Justice. 16:452–469.
   Google Scholar
• Taylor S. 2016. Moving beyond the other: a critique of the reductionist drugs discourse. Tijdschrift over Cultuur and Criminaliteit. 6:100–118.
   Google Scholar
• Toole P. 2019. Ministerial media release: NSW Government releases list of higher risk music festivals. [accessed 2019 Dec 11]. https://www.liquorandgaming.nsw.gov.au/news-and-media/ministerial-media-release-nsw-government-releases-list-of-higher-risk-music-festivals.
   Google Scholar
• Tupper K. 2008. The globalisation of ayahuasca: harm reduction or benefit maximization? Int J Drug Policy. 19:297–303.
   PubMed Web of Science ®Google Scholar
• van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. 2013. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 131:23–35.
   PubMed Web of Science ®Google Scholar
• von Hippel C, Brener L, Horwitz R. 2018. Implicit and explicit internalized stigma: relationship with risky behaviors, psychosocial functioning and healthcare access among people who inject drugs. Addict Behav. 76:305–311.
   PubMed Web of Science ®Google Scholar
• Willis LL. 2016. Deconstructing divergent constructions of illicit drug use and drug-using subjects: understanding enduring stigma and marginalisation [dissertation]. Perth: Curtin University.
   Google Scholar
• Wilson L, Vannice S, Hacksel C, Leonard L. 2018. Peer worker or client?: conflicting identities among peer workers engaged in harm reduction service delivery. Addict Res Theory. 26:361–368.
   Web of Science ®Google Scholar